Revealed: The ‘Star Wars’ Movie With The Highest Profits

Disney's 'TRON: Ares' has experienced a significant decline at the box office, dropping 66% in its second weekend. This sharp decrease raises concerns about the film's overall performance and its potential impact on future projects in the franchise. With audiences seemingly less interested, it highlights the challenges Disney faces in reviving beloved properties.

PepsiCo is showing signs of recovery with better-than-expected third-quarter results, surpassing analysts' sales and profit forecasts. This positive momentum has caught the attention of Wall Street, which is cautiously optimistic about the company's future. As the world's largest food and drink company addresses its previous challenges, it remains to be seen how much this will resonate with shoppers, but the financial performance indicates a promising turnaround.

Disney's Marvel Studios has surprised fans with a project that cost only $30.4 million, a fraction of its usual blockbuster budgets. This news is significant as it showcases the studio's ability to create compelling content without the hefty price tag, potentially opening doors for more innovative storytelling and diverse projects in the future.

This week, fans of horror and thriller genres can look forward to 'The Long Walk,' a new film based on Stephen King's novel, hitting digital streaming platforms. This release is significant as it brings a beloved literary work to life, allowing viewers to experience the chilling narrative from the comfort of their homes.

Disney's latest effort to revive the 'Tron' franchise has flopped, signaling a potential end for the series. Meanwhile, 'One Battle After Another' is thriving, contributing to a successful year for Warner Bros. This contrast highlights the challenges faced by established franchises in a competitive market, while also showcasing the potential for new stories to resonate with audiences.

Cleveland-Cliffs is experiencing a surge in demand for its steel products, thanks in part to favorable trade policies from the Trump administration that support U.S. manufacturing. The company is also looking to diversify its operations by exploring the production of rare-earth minerals, which are crucial for various high-tech applications. This move not only strengthens its market position but also highlights the growing importance of domestic production in the face of global supply chain challenges.

Kering has announced a significant $4.7 billion deal to sell its beauty business to L’Oréal, marking a strategic move by the new CEO, Luca de Meo, to rejuvenate the company's performance. This sale is crucial as it allows Kering to focus on its core luxury brands while L’Oréal expands its portfolio in the beauty sector. Such a transaction not only reflects the evolving landscape of luxury and beauty but also highlights Kering's commitment to strengthening its market position.

Amazon's AWS experienced significant disruptions, leading to outages for hundreds of websites for several hours. This incident highlights the vulnerability of online services that rely on cloud infrastructure, affecting businesses and users alike. The impact of such outages can be far-reaching, causing loss of revenue and frustrating users who depend on these platforms for daily activities.

Crude oil prices are continuing to decline due to concerns over supply and demand. Factors such as weak growth projections, the ongoing energy transition in China and the EU, and tensions from U.S.-China tariffs are contributing to this negative outlook. This matters because fluctuations in oil prices can significantly impact global economies and consumer behavior.

Merck has released long-term data demonstrating that its cancer treatment, KEYTRUDA, continues to provide significant survival benefits for patients with lung cancer. This is important because it reinforces the effectiveness of KEYTRUDA as a vital option in cancer therapy, potentially improving the quality of life for many patients facing this challenging disease.

Abbvie's stock price target has been raised to $258 from $240 by BMO Capital, reflecting growing confidence in the company's future performance. This adjustment is significant as it indicates analysts' optimism about Abbvie's potential for growth and profitability, which could attract more investors and positively impact the stock market.